These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18591101)

  • 1. No change in striatal glutamate in Huntington's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Quarrell OW
    Parkinsonism Relat Disord; 1998 Oct; 4(3):123-7. PubMed ID: 18591101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M; Horsman A
    Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
    Clarke CE; Lowry M
    Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory.
    Taylor-Robinson SD; Weeks RA; Bryant DJ; Sargentoni J; Marcus CD; Harding AE; Brooks DJ
    Mov Disord; 1996 Mar; 11(2):167-73. PubMed ID: 8684387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical correlates of caudate atrophy in Huntington's disease.
    Padowski JM; Weaver KE; Richards TL; Laurino MY; Samii A; Aylward EH; Conley KE
    Mov Disord; 2014 Mar; 29(3):327-35. PubMed ID: 24442623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal evaluation of proton magnetic resonance spectroscopy metabolites as biomarkers in Huntington's disease.
    Lowe AJ; Rodrigues FB; Arridge M; De Vita E; Johnson EB; Scahill RI; Byrne LM; Tortelli R; Heslegrave A; Zetterberg H; Wild EJ
    Brain Commun; 2022; 4(6):fcac258. PubMed ID: 36382217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity in 1H-MRS profiles of presymptomatic and early manifest Huntington's disease.
    Reynolds NC; Prost RW; Mark LP
    Brain Res; 2005 Jan; 1031(1):82-9. PubMed ID: 15621015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal metabolite changes in Huntington's disease during disease onset.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; van Buchem MA; Roos RA; van der Grond J
    J Huntingtons Dis; 2014; 3(4):377-86. PubMed ID: 25575959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo magnetic resonance spectroscopy of human fetal neural transplants.
    Ross BD; Hoang TQ; Blüml S; Dubowitz D; Kopyov OV; Jacques DB; Lin A; Seymour K; Tan J
    NMR Biomed; 1999 Jun; 12(4):221-36. PubMed ID: 10421914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.
    van den Bogaard SJ; Dumas EM; Teeuwisse WM; Kan HE; Webb A; Roos RA; van der Grond J
    J Neurol; 2011 Dec; 258(12):2230-9. PubMed ID: 21614431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Alterations Within the Primary Visual Cortex in Early Open-angle Glaucoma Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Guo L; Wang R; Tang Z; Sun X; Wu L; Wang J; Zhong Y; Xiao Z; Zhang Z
    J Glaucoma; 2018 Dec; 27(12):1046-1051. PubMed ID: 30256276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case control study: magnetic resonance spectroscopy of brain in HIV infected patients.
    Bairwa D; Kumar V; Vyas S; Das BK; Srivastava AK; Pandey RM; Sharma SK; Jagannathan NR; Sinha S
    BMC Neurol; 2016 Jul; 16():99. PubMed ID: 27405321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
    Hazany S; Hesselink JR; Healy JF; Imbesi SG
    Neuroradiology; 2007 Feb; 49(2):121-7. PubMed ID: 17086406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
    Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
    Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine supplementation lowers brain glutamate levels in Huntington's disease.
    Bender A; Auer DP; Merl T; Reilmann R; Saemann P; Yassouridis A; Bender J; Weindl A; Dose M; Gasser T; Klopstock T
    J Neurol; 2005 Jan; 252(1):36-41. PubMed ID: 15672208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
    Burger A; Brooks SJ; Stein DJ; Howells FM
    Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased glutamate + glutamine levels in the thalamus of patients with essential tremor: A preliminary proton MR spectroscopic study.
    Barbagallo G; Arabia G; Novellino F; Nisticò R; Salsone M; Morelli M; Rocca F; Quattrone A; Caracciolo M; Sabatini U; Cherubini A; Quattrone A
    Parkinsonism Relat Disord; 2018 Feb; 47():57-63. PubMed ID: 29203059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior Cingulate Cortex Glutamatergic Metabolites and Mood Stabilizers in Euthymic Bipolar I Disorder Patients: A Proton Magnetic Resonance Spectroscopy Study.
    Soeiro-de-Souza MG; Otaduy MCG; Machado-Vieira R; Moreno RA; Nery FG; Leite C; Lafer B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Dec; 3(12):985-991. PubMed ID: 29789269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T.
    Antuono PG; Jones JL; Wang Y; Li SJ
    Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.